Meeting with Beijing Food and Drug Administration

2017-07-14 | Beijing

Representatives from relevant working groups, including AFB, Pharma, Medical Devices, and Cosmetics learned from the Director General and relevant Division Directors on their next stage work plan and priorities of post market surveillance of different sectors of Beijing FDA. It was a very effective communication. The members not only built up contacts with the leadership of Beijing FDA, but also expressed key concerns and received comments and suggestions from Beijing FDA.